Search Login Register

Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) Summary

Description: FIBROUS DYSPLASIA OF BONE affecting several or many bones. When associated with melanotic pigmentation of the skin and endocrine disorders, it is known as Albright's syndrome. (From Dorland, 28th ed)

Also Known As: McCune Albright Syndrome; Albright Syndrome; Syndrome, Albright's; Syndrome, McCune-Albright; Albright's Syndrome Show All >>

Networked: 320 relevant articles (13 outcomes, 11 trials/studies) for this Disease

Key Drugs and Agents for Polyostotic Fibrous Dysplasia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Testolactone (Teslac) : 4 outcomes in 10 results : FDA 2
  2. Gonadotropin-Releasing Hormone (GnRH) : 2 outcomes 1 study in 9 results : FDA 2
  3. Aromatase (CYP19) : 2 outcomes in 9 results : IBA
  4. pamidronate (APD) : 1 outcome 1 study in 12 results : FDA 16 Generic
  5. Estrogens (Estrogen) : 1 outcome 1 study in 11 results : FDA 1
  6. Tamoxifen : 1 outcome 1 study in 7 results : FDA 12 Generic
  7. fulvestrant (Faslodex) : 1 outcome 1 study in 1 result : FDA 1
  8. Familial Testotoxicosis : 1 outcome in 12 results : IBA
  9. Alendronate (Alendronate Sodium) : 1 outcome in 5 results : FDA 18 Generic
  10. Aromatase Inhibitors : 1 outcome in 3 results : IBA
Show All >>

Diseases Related to Polyostotic Fibrous Dysplasia

  1. Precocious Puberty
  2. Gynecomastia
  3. Neoplasms (Cancer)
  4. Cushing Syndrome
  5. Pain (Aches)
Show All >>

Key Therapies for Polyostotic Fibrous Dysplasia

Efficacy Chart >>
  1. Ovariectomy (Oophorectomy) : 1 outcome 1 study in 4 results
  2. Adrenalectomy : 1 outcome in 5 results
  3. Aftercare (After-Treatment) : 1 outcome in 4 results
  4. Osteotomy : 7 results
  5. Decompression : 4 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.